Moderna Inc (MRNA) — Technical state
As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Uptrend stack intact — Trades +27.5% vs the 50-day and +168% vs the 200-day average, 10.7% below the 52-week high and +1025.8% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
- Trend: Moderna Inc trades 27.5% above its 50-day and 168.0% above its 200-day moving average. (as of 2026-11-10)
Moderna develops messenger RNA medicines, a technology that instructs cells to make a protein rather than delivering the protein itself. Its portfolio spans respiratory vaccines for COVID, RSV and influenza, vaccines against latent viruses and other pathogens, and early oncology and rare-disease programmes.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the MRNA overview. Research diary readings, not advice.
Trades +27.5% vs the 50-day and +168% vs the 200-day average, 10.7% below the 52-week high and +1025.8% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+9.4%
- vs 50-day+27.5%
- vs 200-day+168%
- 52-week band10.7% off the high · +1025.8% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed up through the 50-day 65 sessions ago
- Stochastic%K 70.4 · %D 83.1 · bear cross
Continue: the MRNA chart & overview · the signal board
FAQ · from the current data · as of 2026-11-10
Quick answers
What is the current Closelooknet signal on MRNA?
Uptrend stack intact — Trades +27.5% vs the 50-day and +168% vs the 200-day average, 10.7% below the 52-week high and +1025.8% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is MRNA above its 50-day and 200-day moving averages?
As of 2026-11-10, Moderna Inc trades +27.5% above its 50-day and +168% above its 200-day average, with the 20-day +9.4% away.
How far is MRNA from its 52-week high?
10.7% below the 52-week high and 1025.8% above the 52-week low, as of 2026-11-10.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeOne Medicines AGindustry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry
- XNCR Xencor Incindustry
- VCEL Vericel Corp Ordindustry
- VRDN Viridian Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- ORKA Oruka Therapeutics, Inc.industry
- ADMA ADMA Biologics Incindustry
- PHARM.AS Pharming Group NVindustry
- MEDCL.PA Medincell SAindustry
- DNA Ginkgo Bioworks Holdingsindustry
- NEU.AU Neuren Pharmaceuticals Ltdindustry
- IRON Disc Medicine Inc.industry